{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-270145","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.065768+00:00","generated_at":"2026-05-16T23:25:13.684815+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"EyePoint Pharmaceuticals files $200M ATM equity offering with Cantor Fitzgerald","bullets":["Registered at-the-market offering of up to $200 million of common stock under a prospectus supplement filed November 6, 2025.","Sales agreement with Cantor Fitzgerald & Co. dated August 5, 2020 governs the offering.","Proceeds expected for general corporate purposes; legal opinion from Hogan Lovells filed as exhibit."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-270145","json":"https://secwatch.observer/filing/0001193125-25-270145.json","markdown":"https://secwatch.observer/filing/0001193125-25-270145.md","text":"https://secwatch.observer/filing/0001193125-25-270145.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000119312525270145/0001193125-25-270145-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000119312525270145/d80838d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:25:13.684815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}